Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces left ventricular hypertrophy; however, its role in arterial calcification is less clear. In order to study this we quantif...

詳細記述

保存先:
書誌詳細
主要な著者: Scialla, Julia J., Lau, Wei Ling, Reilly, Muredach P., Isakova, Tamara, Yang, Hsueh-Ying, Crouthamel, Matthew H., Chavkin, Nicholas W., Rahman, Mahboob, Wahl, Patricia, Amaral, Ansel P., Hamano, Takayuki, Master, Stephen R., Nessel, Lisa, Chai, Boyang, Xie, Dawei, Kallem, Radhakrishna R., Chen, Jing, Lash, James P., Kusek, John W., Budoff, Matthew J., Giachelli, Cecilia M., Wolf, Myles
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3672330/
https://ncbi.nlm.nih.gov/pubmed/23389416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2013.3
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料